Company
United StatesPublic company, NYSE: BMYBristol-Myers Squibb Company (NYSE: BMY), Princeton, NJ – FDA Inspections
Inspection records and compliance data for Bristol-Myers Squibb Company in Princeton, New Jersey. 6 FDA inspections on record, 1 Form 483, last inspected April 24, 2024. Publicly traded as NYSE: BMY.
Company Profile
This profile covers Bristol-Myers Squibb Company based in Princeton, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 6
- OAI
- 0
- VAI
- 3
- NAI
- 2
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected August 20, 2009. Last inspected April 24, 2024.
Most cited issue areas
- Failure to submit scientific article2 inspections
- Late submission of annual safety reports1 inspection
- Late submission of quarterly safety reports1 inspection
FDA inspections (6)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 24, 2024 | NAI | Human Drugs · Bioresearch Monitoring | 1236867 |
| March 7, 2019 | VAI | Human Drugs · Bioresearch Monitoring | 1083235 |
| September 7, 2018 | Not classified | Human Drugs | 1066837 |
| April 27, 2016 | VAI | Human Drugs · Bioresearch Monitoring | 972194 |
| May 2, 2013 | VAI | Human Drugs · Bioresearch Monitoring | 829516 |
| August 20, 2009 | NAI | Human Drugs · Bioresearch Monitoring | 603837 |
FDA documents
Other FDA documents (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Bristol-Myers Squibb Company
Stock ticker
BMY
Exchange
NYSE
Share price
$62.37
Market cap
$127.5B
Price as of
November 13, 2026
FEI Number
3002708128
Address
3551 Lawrenceville Rd, Princeton, New Jersey 08540, United States
Country
United States
ID: f88df458-d615-433c-956b-d484506e4986